Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexrabeprazole Effect on Acidity in GERD
NCT02689999Phase 4Completed
- Sponsor
- Neutec Group
- Start
- Feb 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexrabeprazole in gastroesophageal reflux disease (GERD), sponsored by Neutec Group. Started Feb 2016; status: completed.
02
Drugs
dexrabeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02689999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02689999.